Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples